IOVANCE BIOTHERAPEUTICS, INC.·4

Jun 2, 8:02 PM ET

Maynard Ryan D 4

4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Jun 2, 2022

Insider Transaction Report

Form 4
Period: 2022-05-31
Transactions
  • Purchase

    Common Stock

    2022-05-31$6.75/sh+7,500$50,5887,500 total

Documents

1 file
  • 4
    tm2217576d4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT